EGFR/c-SRC-IN-1
EGFR/c-SRC-IN-1 is a blood-brain barrier-impermeable, ATP-competitive dual-target inhibitor of EGFR/c-SRC, with an IC50 of 0.05 μM against EGFR and an IC50 of 0.07 μM against c-SRC. EGFR/c-SRC-IN-1 shows selectivity toward ABL-2 and VEGFR-2 kinases. EGFR/c-SRC-IN-1 triggers endogenous apoptosis by upregulating p53 and Bax, downregulating Bcl-2, and altering the Bax/Bcl-2 ratio. EGFR/c-SRC-IN-1 can be used in the research of non-small cell lung cancer, hepatocellular carcinoma, and triple-negative breast cancer.
For research use only. We do not sell to patients.
- Formula: C23H17F3N4O2
- Molecular Weight:438.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
|
SRC-3 0.05 μM (IC50) |
EGFR/c-SRC-IN-1 (compound 9b) (0.04-100 μM; 24 h) potently inhibits the proliferation of A549, HepG2, and MDA-MB-468 cancer cells with IC50 values of 0.61 μM, 1.47 μM, and 9.14 μM, respectively[1].
EGFR/c-SRC-IN-1 induces G0/G1 cell cycle arrest in A549 cells, reducing progression to S and G2/M phases[1].
EGFR/c-SRC-IN-1 potently induces apoptosis in A549 cells, increasing total apoptotic populations by approximately 10-fold while leaving necrotic cell levels largely unchanged[1].
EGFR/c-SRC-IN-1 modulates apoptotic gene expression in A549 cells, upregulating pro-apoptotic p53 and Bax while downregulating anti-apoptotic Bcl-2[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 438.40
-
Formula C23H17F3N4O2
-
SMILES
O=C(NC1=CC=C(C(F)(F)F)C=C1)NN2C(C)=NC3=C(C=C(C4=CC=CC=C4)C=C3)C2=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)